Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 6:2:100017.
doi: 10.1016/j.obpill.2022.100017. eCollection 2022 Jun.

Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

Justin Tondt  1 , Harold Edward Bays  2
Affiliations

Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

Justin Tondt et al. Obes Pillars. .

Abstract

Background: This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians an overview of the body weight effects of concomitant medications (i.e., pharmacotherapies not specifically for the treatment of obesity) and functional foods, as well as adverse side effects of supplements sometimes used by patients with pre-obesity/obesity.

Methods: The scientific information for this CPS is based upon published scientific citations, clinical perspectives of OMA authors, and peer review by the Obesity Medicine Association leadership.

Results: This CPS outlines clinically relevant aspects of concomitant medications, functional foods, and many of the more common supplements as they relate to pre-obesity and obesity. Topics include a discussion of medications that may be associated with weight gain or loss, functional foods as they relate to obesity, and side effects of supplements (i.e., with a focus on supplements taken for weight loss). Special attention is given to the warnings and lack of regulation surrounding weight loss supplements.

Conclusions: This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) on concomitant medications, functional foods, and supplements is one of a series of OMA CPSs designed to assist clinicians in the care of patients with the disease of pre-obesity/obesity. Implementation of appropriate practices in these areas may improve the health of patients, especially those with adverse fat mass and adiposopathic metabolic consequences.

Keywords: Clinical practice statement; Concomitant medications; Functional foods; Obesity; Supplements.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Bays H.E., McCarthy W., Burridge K., Tondt J., Karjoo S., Christensen S., Ng J., Golden A., Davisson L., Richardson L. 2021. Obesity Algorithm eBook.www.obesityalgorithm.orghttps://obesitymedicine.org/obesity-algorithm/ presented by the Obesity Medicine Association.
    1. Pillinger T., McCutcheon R.A., Vano L., Mizuno Y., Arumuham A., Hindley G., et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatr. 2020;7:64–77. - PMC - PubMed
    1. Uguz F., Sahingoz M., Gungor B., Aksoy F., Askin R. Weight gain and associated factors in patients using newer antidepressant drugs. Gen Hosp Psychiatr. 2015;37:46–48. - PubMed
    1. Valle-Cabrera R., Mendoza-Rodriguez Y., Robaina-Garcia M., Ballesteros J., Cordero-Jimenez J.R., Espinosa-Rodriguez N.B., et al. Efficacy of sertraline in patients with major depressive disorder naive to selective serotonin Reuptake inhibitors: a 10-week randomized, multicenter, placebo-controlled, double-blind, academic clinical trial. J Clin Psychopharmacol. 2018;38:454–459. - PubMed
    1. Rachdi C., Damak R., Fekih Romdhane F., Ouertani H., Cheour M. Impact of sertraline on weight, waist circumference and glycemic control: a prospective clinical trial on depressive diabetic type 2 patients. Prim Care Diabet. 2019;13:57–62. - PubMed

LinkOut - more resources